Biograil
Biograil is a biotech company manufacturing an oral device for delivery of biologics
Biograil has raised €3.0M across 1 funding round from 1 investor, most recently a Seed round in Jan 2020. Based in Copenhagen, Denmark; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-01
latest 2020-01
Funding by year
EUR raised per yearBiograil — funding by year — interactive chart.
Data table
| Biograil — funding by year | |
|---|---|
| 2020 | €3.0M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-01-15 | Seed | €3.0M | High-Tech Gründerfonds (HTGF) | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData